Locations:
Search IconSearch

Outcome Highlights in Adult Cardiac Surgery, Ischemic Heart Disease and Vascular Surgery

A scannable recap of our latest data in these clinical areas

Below we share recent volumes and clinical outcomes from a sampling of disciplines and subspecialty areas in Cleveland Clinic’s Heart, Vascular and Thoracic Institute: adult cardiac surgery, ischemic heart disease and vascular disease.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

ADULT CARDIAC SURGERY

two blue-shaded boxes containing text and star rankings

Operative Mortality, First Half of 2025

tabular chart with three columns and eight rows

STS = Society of Thoracic Surgeons; ACC = American College of Cardiology; TVT = Transcatheter Valve Therapy
CABG = coronary artery bypass grafting; AVR = aortic valve replacement; MVRR = mitral valve repair/replacement; TAVR = transcatheter aortic valve replacement; MVR = mitral valve replacement

ISCHEMIC HEART DISEASE

SURGICAL TREATMENT

2,015

CABG volume in 2024:

  • 994 isolated CABG
  • 1,021 CABG + other
  • 143 (7.1%) were reoperations
two tabular charts stacked one above the other

PERCUTANEOUS CORONARY INTERVENTION (PCI) IN 2024

1,519

Percutaneous coronary interventions

61.5%

Same-day discharge rate for elective PCI cases

1.46%

PCI risk-standardized mortality (all patients), better than the 1.93% NCDR 50th percentile rate

1.04%

PCI risk-standardized mortality for STEMI patients (without cardiogenic shock or cardiac arrest), better than the 1.89% NCDR 50th percentile rate

56 minutes

Median time to PCI for STEMI patients, better than the NCDR 50th percentile of 63 minutes

97.96%

Proportion of STEMI patients receiving PCI within 90 minutes, better than the 93.96% NCDR 50th percentile rate

(Source: National Cardiovascular Data Registry, CathPCI Registry®, American College of Cardiology Foundation, for rolling four-quarter period through Q4 2024)
NCDR = National Cardiovascular Data Registry; STEMI = ST-elevation myocardial infarction

VASCULAR DISEASE

bar graph with three annual columns
bar graph with three columns showing numbers for three years
tabular chart listing mortality rates for surgical procedures

2024 MORTALITY RATES FOR ABDOMINAL AORTIC ANEURYSM (AAA) REPAIR

0%

Elective open AAA repair (N = 102)

11.1%

Ruptured open AAA repair (N = 18)

0.8%

Elective endovascular AAA repair (N = 130)

0%

Ruptured endovascular AAA repair (N = 15)


Cleveland Clinic’s Heart, Vascular and Thoracic Institute has a long tradition of reporting volume and outcomes data across its subspecialty areas. For more information like the data reported above, visit clevelandclinic.org/hvtioutcomes and clevelandclinic.org/e15.

Advertisement


Advertisement

Related Articles

exterior of a large modern medical building
From Observation to Implementation: What Alliance Hospitals Gain From Visiting Cleveland Clinic

Site visits offer firsthand lessons in clinical and operational excellence in cardiovascular care

Diabetic retinopathy
Anti-VEGF in the Real World: Who Is at Risk of Vision Loss After Lapse in Treatment?

Study identifies factors that may predict vision outcomes in diabetic macular edema

two medical procedures with plus/minus sign between them
PCI for Stable CAD in Patients Undergoing TAVR: Debate Endures Despite New Data

In the wake of NOTION-3 findings, a strong argument for physician judgment remains

coronary chronic total occlusion
Bringing More Options to Bear in CAD – Part 3: Refinements in Revascularization Care

The case for a thoughtful approach to CTO and minimally invasive options for CABG

angiogram showing microvascular disease
Bringing More Options to Bear in CAD – Part 2: Meeting Needs of Special Patient Populations

Resourceful approaches to the care of patients with microvascular disease and elevated Lp(a)

series of cardiac pet scans
Bringing More Options to Bear in CAD – Part 1: Noninvasive Functional Testing for Obstructive Disease

Novel approaches are available for patients at all stages of coronary artery disease

atherosclerosis in coronary artery
Untreated Obstructive Coronary Artery Disease Safe in TAVR Recipients, Study Shows

Support for a TAVR-first approach in patients with concurrent valve and coronary disease

Ad